JCDR - Register at Journal of Clinical and Diagnostic Research
Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X
Education Section DOI : 10.7860/JCDR/2018/31060.11348
Year : 2018 | Month : Apr | Volume : 12 | Issue : 4 Full Version Page : JC07 - JC10

Effects of Continuous Care Model on Blood Pressure in Patients with Type II Diabetes

Milad Borji1, Asma TaRjoman2, Reza Seymohammadi3, Ebrahim Salimi4, Masoumeh Otaghi5

1 Department of Nursing, Ilam University of Medical Sciences, Ilam, Iran.
2 Student Research Committee, Ilam University of Medical Sciences, Ilam, Iran.
3 Student Research Committee, Ilam University of Medical Sciences, Ilam, Iran.
4 Department of Nursing, Ilam University of Medical Sciences, Ilam, Iran.
5 Department of Nursing, Ilam University of Medical Sciences, Ilam, Iran.


NAME, ADDRESS, E-MAIL ID OF THE CORRESPONDING AUTHOR: Mr. Masoumeh Otaghi, Department of Nursing, Ilam University of Medical Sciences, Ilam-6939177143, Iran.
E-mail: masoome.otaghi@gmail.com
Abstract

Introduction

One of the main problems encountered by type II diabetes patients is high Blood Pressure (BP). Continuous care is the standard process of making effective, mutual, and continuous relationships between patients and nurses as healthcare providers. Continuous Care Model (CCM) can help the nurses in identifying needs, problems, and sensitisations of the patients and encourage them to maintain and enhance their health status.

Aim

This study aimed to investigate the effects of CCM on the BP trends of patients with type II diabetes in Ilam city.

Materials and Methods

This quasi-experimental research was conducted in 80 patients with type II diabetes. Subjects were selected using cluster sampling method and then were randomly divided into intervention and control groups. Interventions based on the CCM were in the form of training sessions that were conducted for three weeks. Consequently, continuous care consultations, control, and assessment were conducted for nine weeks. A questionnaire on demographic characteristics and a BP recording device was used to collect the data obtained before intervention and 1-3 months after intervention. Then, descriptive and inferential tests. Then, (ANOVA repeated measures, chi-square) were used for data analysis.

Results

Findings revealed that the mean BP (measured in mmHg) scores of the CCM (systolic, 133.22±3.98; diastolic, 86.00±2.96) and control groups (systolic, 133.65±2.10; diastolic 84.62±2.72) before intervention were not significant (p>0.05); however, after intervention, a significant difference was observed between the mean BP (measured in mmHg) scores of the CCM (systolic, 127.52±3.13; diastolic, 80.75±1.97) and control groups (systolic, 133.65±2.25; diastolic, 83.87±2.12) (p<0.05).

Conclusion

CCM is suggested to be effective in managing the BP and can be applied to improve the health behaviour in patients with type II diabetes.

Keywords

Introduction

Diabetes is a multifactorial metabolic disorder characterised by increased blood glucose due to defect in secretion or action of insulin, or both. Diabetes results in 2.5-15% increased cost of healthcare budget, and indirect costs reach manifold. It is also responsible for ischaemic heart disease, hypertension, retinopathy, neuropathy, and cataract and for 9% of all deaths worldwide. Therefore, diabetes is considered as a major general healthcare problem in the USA and other parts of the world, particularly in Iran [1-6]. The prevalence of type II diabetes is increasing worldwide [7-9]. The number of patients suffering from type II diabetes is estimated to be at least 350 million individuals by the year 2030 [5,10-13]. The complications of diabetes can be increased risk of cancer [14,15], cardiovascular outcomes [16] and decrease in quality of life [17]. One of the main problem in patients with diabetes is high BP, which is continuously growing due to the high prevalence and concurrency of cardiovascular diseases in industrial and developing countries [18]. High BP in the middle east is one of the non communicable diseases with a significantly increased prevalence [19]. Therefore, appropriate interventions to manage hypertension seem significant.

One of the methods used by proficient nurses is the care model. In Iran, the CCM was developed and evaluated by Rahimi A et al., in relation with chronic diseases. This model introduces patients as the continuous and effective caring factor in promoting their health [20,21]. Continuous care is a process of making effective, mutual, and continuous relationships between patients and nurses as healthcare providers who identify patients’ needs, problems, and sensitisation for acceptance of continuous healthcare behaviours and contribution in keeping improved and enhanced health [22,23]. Applying this mode is accurately identifying patients’ problems and motivating and involving them and their families to eliminate their problems [24]. The main objective of the CCM is designing and developing a program that results in acceptance, increased appropriate visions, and controlling the diseases and potential side effects [25].

The results of this study may improve the knowledge-based evidence on caring of patients with diabetes to facilitate a more specialised care. It also motivates nurses, patients, caregivers, and family members for implementing CCM and controlling disease consequences. Therefore, given the prevalence of diabetes [26,27] this study was conducted aiming to determine the effects of CCM on the BP of patients with diabetes in Ilam city.

Materials and Methods

The present quasi-experimental research with pre test-post-test stages was conducted on 80 patients with type II diabetes who visited the health care centers. They were divided into control and intervention groups. The sample size was considered 80 according to the Cochran formula with a confidence interval of 95% and a statistical power of 80%. In every province of Iran, there are many health care centers that serve people at primary prevention level. In the city of Ilam, there are 11 health care centers. The patients were selected from the health centers by cluster sampling. Then they were divided into two groups of intervention and control. Patients who referred on even days were placed in the control group and who referred on odd days were placed in the experimental group. Patients and data collectors were blinded (double blind). Inclusion criteria were patients suffering from type II diabetes for at least one year, with age ranging from 18 to 65 years and literate. Exclusion criteria were patients suffering from diabetes type I, absent for more than two sessions of training interventions, hospitalisation during intervention, risk of diabetic ketoacidosis or non ketone hyperosmolar hyperglycaemic syndrome, suffering from cardiovascular diseases, and well-known psychological disorders.

Training sessions were conducted for three weeks, and subsequently, consultants of continuous care, control, and assessments were followed up for nine weeks. Data collection instruments were divided into two parts: personal characteristics (age, gender, marital status, education, monthly income, suffering from diabetes, etc.) and the BP measurement. BP was measured and recorded for all patients at 0, 1, 2 and 3 months of the study. To measure the BP, patients were left in a quiet environment for five minutes, and tea, coffee, and cigarettes were not allowed. The BP by mercury manometer was measured from the left hand, in supine position. Before conducting the study, the reliability of the instrument was confirmed on 10 patients.

The CCM included four phases: orientation, sensitisation, control, and evaluation which was conducted for four interventional groups including seven or eight members.

Orientation phase: A session was held for 10 to 15 min. in the presence of the researcher, patients, and family members. Participants and the researchers stated their expectations from the course and emphasised the relationship between continuation of care and treatment. In this phase, moral considerations and demographic information questionnaire forms were conducted.

Sensitisation phase: This phase aimed at partcipation of patients’ and family member’s in implementing care for 4-6 sessions in 30-45 minutes with regard to the level of tolerance and acceptance of patients and their families. Then, the researcher informed the subjects, in an understandable way, about the characteristics of diabetes, control of side effects of the disease, significance of diet, physical activities, regular visits to physicians, observation of given prescriptions, and other factors affecting BP. Moreover, the significance of regular visits to the physicians and how to perform the prescribed procedures, giving up inappropriate habits such as smoking, continuation of care behaviours, and discussion about considered questions and answers were taken into account. Personal sessions for complete discussions and also for those who were absent during the sessions were held. First and second stages took about three weeks.

Control phase: In investigating and paying attention to new care problems (hospitalisation and mode of continuing learned behaviours) and keeping mutual relations (via phone calls or face-to-face relations), consultations were continued and the process of problem solving was decided. This period took one week.

Evaluation phase: This phase included investigation of patients’ BP evaluated at one, two, and three months in both intervention and control groups.

Ethical approval was taken from The Ethical Committee of Ilam University of Medical Sciences (ir.medilam.rec.1396.43) and informed consent was taken from the participants for this research.

Statistical Analysis

Data were analysed using the SPSS version 20.0 and descriptive statistics (mean scores, percentage, and absolute and relative frequency) for personal variables, and chi-square test for comparing personal variables of the two groups. The repeated measure ANOVA was employed to compare the BP before and after the intervention.

Results

Among the 80 subjects participating in the study, 48 (60%) were male and 32 (40%) were female. Statistical tests indicated no significant differences between the intervention and control group in terms of demographic variables [Table/Fig-1].

Demographic characteristics of research samples.

Demographical characteristicsIntervention group n (%)Control group n (%)p-value
GenderMen25 (62.5)23 (57.5)0.38
Women15 (37.5)17 (42.5)
Marital statusMarried36 (90)37 (92.5)0.43
Single4 (10)3 (7.5)
EducationPrimary10 (25)11 (27.5)0.88
Secondary6 (15)10 (25)
High school15 (37.5)12 (30)
University9 (22.5)7 (17.5)
JobEmployed7 (17.5)4 (10)0.93
Housewives16 (40)14 (35)
Self-employed15 (37.5)20 (50)
Unemployed2 (5)2 (5)
Income per monthLess than 500 thousand tomans15 (37.5)17 (42.5)0.74
From 500 to 1 million tomans6 (15)7 (17.5)
More than 1 million tomans19 (47.5)16 (40)
SmokingYes7 (17.5)10 (25)0.10
No33 (82.5)30 (75)
Regular visits to physicianYes8 (20)9 (22.5)0.60
No32 (80)31 (77.5)
Family history of diabetesYes15 (37.5)19 (47.5)0.42
No17 (42.5)21 (52.5)

ANOVA and Chi-square tests were used for comparing quantitative and qualitative data.


Findings in [Table/Fig-2,3] indicate that the BP in the intervention group decreased after the intervention. ANOVA indicated a significant difference between BP of the control and intervention groups (p<0.05).

Comparison of systolic blood pressure before, 1, 2, and 3 months after the intervention.

Systolic blood pressureIntervention groupControl group
Mean±SDp-valueMean±SDp-value
Before intervention133.22±3.98-133.65±2.10-
One month after intervention130.22±2.020.01133.77±2.220.35
Two months after intervention129.77±3.660.01134.02±2.870.38
Three months after intervention127.52±3.130.01133.65±2.250.42
Variance analysis with repeated measurep=0.01 df=3

Analysis of variance with repeated measure was used to compare means in three groups

SD-Standard Deviation


Comparison of diastolic blood pressure before, 1, 2, and 3 months after the intervention.

Diastolic blood pressureIntervention groupControl group
Mean±SDp-valueMean±SDp-value
Before intervention86.00±2.96-84.62±2.72-
One month after intervention83.22±3.740.0184.42±2.720.30
Two months after intervention82.50±2.070.0184.37±2.690.33
Three months after intervention80.57±1.970.0183.87±2.120.32
Variance analysis with repeated measurep=0.01 df=3

Analysis of variance with repeated measure was used to compare means in three groups

SD-Standard Deviation


Discussion

This study aimed to investigate the effects of CCM on the BP trends of patients with type II diabetes in Ilam city. Our results showed that before conducting intervention, the systolic and diastolic BP in most of the subjects was >130 mmHg and >80 mmHg, respectively. Ghavami H et al., and Shahbodaghi Z et al., studies are consistent with the results of the present study [25,28]. In Abbasian M and Delvarianzadeh M study conducted on 340 patients with type II diabetes, findings indicated that 34.8% of the patients had history of high BP [29]. Grobbee DE also reported that cardiovascular diseases and high BP were among the prevalent problems in diabetic patients [30]. In Bonakdaran S and Taghavi M study the prevalence of BP in patients with type II diabetes was 51.6% [11]. Diabetic patients who have systolic BP of ≥140 mmHg and diastolic BP of ≥90 mmHg should change their lifestyle and treatment behaviours and receive drugs [31].

Findings of the present study indicated that the CCM causes decreased BP in patients with diabetes as evidenced by a continuously decreasing systolic and diastolic BP after four months; however, significant difference was not observed in the control group. Ghavami H et al., indicated that applying CCM can effectively decrease the mean scores of systolic BP of diabetic patients and prevent the occurrence of side effects by slightly decreasing the systolic and diastolic BP during four continuous months in the intervention group; however, this trend was not observed in the control group [25]. The result of Borji M et al., showed that applying the CCM does not change score of BP in patients on hemodialysis [22].

Raymond I et al., reported that this model caused improvement in the degree of stress, anxiety, and depression in haemodialysis patients [32]. Hashemi S et al., reported that this model caused increased adherence to the diets [33]. Rahimi A et al., estimated the effect of CCM on the Quality of Life (QOL) of haemodialysis patients and observed that in general domains and specific dimensions of QOL, except for the ability to work, the QOL of these patients increased [21].

Limitation

One of the limitation of this study was that measurement using a manual BP cuff may reveal inconsistent and inaccurate results. To resolve this limitation, the validity and reliability of the BP device was confirmed. It is suggested that in subsequent studies, patients’ BP should be monitored using a digital pressure cuff. Other limitations of this study include various factors that may affect the patients’ BP. To resolve this limitation, the researcher tried to identify and control the confounding factors.

Conclusion

This study improves the knowledge based on evidence about caring patients with diabetes, facilitates more specialised care, and motivates nurses, patients, caregivers, and family members in implementing CCM to manage BP. The study again confirmed the effectiveness of this model and indicated that its implementation is appropriately effective on the BP of patients with diabetes. This model is a comprehensive and complete model for caring patients, and its executive stages are compatible with the nursing models. Clinical nurses in different domains of training and nursing management should use this care model.

ANOVA and Chi-square tests were used for comparing quantitative and qualitative data.Analysis of variance with repeated measure was used to compare means in three groupsSD-Standard DeviationAnalysis of variance with repeated measure was used to compare means in three groupsSD-Standard Deviation

References

[1]Ali MK, Bullard KM, Gregg EW, del Rio C, A cascade of care for diabetes in the United States: visualizing the gaps Annals of Internal Medicine 2014 161(10):681-89.10.7326/M14-001925402511  [Google Scholar]  [CrossRef]  [PubMed]

[2]Ghavami H, Ahmadi F, Entezami H, Meamarian R, Survey of effect with diabetes mellitus type II Orumieh in the years 2003 2004:155-79.  [Google Scholar]

[3]Graham JE, Stoebner-May DG, Ostir GV, Al Snih S, Peek MK, Markides K, Health related quality of life in older Mexican Americans with diabetes: a crosssectional study Health Qual Life Outcomes 2007 5(1):3910.1186/1477-7525-5-3917626634  [Google Scholar]  [CrossRef]  [PubMed]

[4]Booya F, Bandarian F, Larijani B, Pajouhi M, Nooraei M, Lotfi J, Potential risk factors for diabetic neuropathy: a case control study BMC Neurology 2005 5(1):2410.1186/1471-2377-5-2416336693   [Google Scholar]  [CrossRef]  [PubMed]

[5]Wild S, Roglic G, Green A, Sicree R, King H, Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 Diabetes Care 2004 27(3):1047-53.10.2337/diacare.27.5.104715111519  [Google Scholar]  [CrossRef]  [PubMed]

[6]Bagheri P, The comparison of prevalence of diabete and hypertension between rural areas of fars and rural area of emro region Iranian Journal of Endocrinology and Metabolism. 2011 13(2):157-64.  [Google Scholar]

[7]Azami M, Moslemirad M, Mansoori A, Khataie M, Sayehmiri K, The prevalence of depression in patients with diabetes in Iran Journal of Babol University of Medical Sciences 2017 19(4):16-27.  [Google Scholar]

[8]Taghinejad H, Tavan H, Evaluating the effect of using training CDs on the patients with Type II diabetes Iranian Journal of Public Health 2018 47(2):301  [Google Scholar]

[9]Behrouzi B, Mohagheghi MA, Sadighi S, Demographic characteristics, survival and prognostic factors of early breast cancer patients with type 2 diabetes mellitus: a hospital-based cohort study Asian Pacific Journal of Cancer Prevention: APJCP 2017 18(9):2485  [Google Scholar]

[10]Fatemeh RN, Hossein DT, Farhad T, Parvin R, Hamidreza T, Islam A, Examining the nourishment status of employees of one of the military universities of Tehran in the month of Ramadan Quran and Medicine 2011 2011(2, Autumn [En]):25-29.  [Google Scholar]

[11]Bonakdaran S, Taghavi M, Cardiovascular risk factors in type 2 diabetic patients in Mashhad City Iranian Journal of Endocrinology and Metabolism 2010 12(1):1-6.  [Google Scholar]

[12]Farvid M, Homayoni F, Neyestani T, Amiri Z, Blood pressure lowering effects of micronutrients in type 2 diabetic patients Iranian Journal of Endocrinology and Metabolism 2010 12(1):7-15.  [Google Scholar]

[13]Aksu H, Pala K, Aksu H, Prevalence and associated risk factors of type 2 diabetes mellitus in Nilufer district, Bursa, Turkey International Journal of Diabetes and Metabolism. 2006 14(2):98  [Google Scholar]

[14]Tabassum I, Mahmood H, Faheem M, Type 2 diabetes mellitus as a risk factor for female breast cancer in the population of Northern Pakistan Asian Pacific Journal of Cancer Prevention: APJCP 2016 17(7):3255-58.  [Google Scholar]

[15]Haseen SD, Khanam A, Sultan N, Idrees F, Akhtar N, Imtiaz F, Elevated fasting blood glucose is associated with increased risk of breast cancer: outcome of case-control study conducted in Karachi, Pakistan Asian Pac J Cancer Prev 2015 16:675-78.10.7314/APJCP.2015.16.2.67525684506  [Google Scholar]  [CrossRef]  [PubMed]

[16]Control D, Trial C, Intensive diabetes treatment and cardiovascular outcomes in type 1 diabetes: the DCCT/EDIC study 30-year follow-up Diabetes care 2016 39(5):686-93.10.2337/dc15-199026861924  [Google Scholar]  [CrossRef]  [PubMed]

[17]Kiadaliri AA, Najafi B, Mirmalek-Sani M, Quality of life in people with diabetes: a systematic review of studies in Iran J Diabetes Metab Disord 2013 12(1):5410.1186/2251-6581-12-5424354933  [Google Scholar]  [CrossRef]  [PubMed]

[18]Meraci M, Feizi A, Bagher NM, Investigating the prevalence of high blood pressure, type 2 diabetes mellitus and related risk factors according to a large general study in Isfahan-using multivariate logistic regression model Pak J Med Sci 2012 28(2):247-52.  [Google Scholar]

[19]Kearney PM, Whelton M, Reynolds K, Whelton PK, He J, Worldwide prevalence of hypertension: a systematic review Journal of Hypertension 2004 22(1):11-19.10.1097/00004872-200401000-0000315106785  [Google Scholar]  [CrossRef]  [PubMed]

[20]Rahimi A, Ahmadi F, Gholyaf M, The effects of continuous care model on depression, anxiety, and stress in patients on hemodialysis Nephrology Nursing Journal 2008 35(1):39  [Google Scholar]

[21]Rahimi A, Ahmadi F, Gholyaf M, Effects of applying continuous care model on quality of life in hemodialysis patients Razi Journal of Medical Sciences 2006 13(52):123-34.  [Google Scholar]

[22]Borji M, Tavan H, Azami M, Otaghi M, The effect of continuous care model on blood pressure and quality of life in patients on hemodialysis Biomedical and Pharmacology Journal 2016 9(2):689-95.10.13005/bpj/991  [Google Scholar]  [CrossRef]

[23]Fadaei M, Damghanian M, Rahimi-Kian F, Tehrani ESN, Mehran A, The effect of educating based on continuous care model on the infertility treatment related quality of life Nursing Practice Today 2016 3(3):81-90.  [Google Scholar]

[24]Sadeghi H, Forouzi M, Haghdust A, Mohammad Alizadeh S, Effect of implementing continuous care model on sleep quality of hemodialysis patients Iran J Crit Care Nurs 2010 3(1):12-18.  [Google Scholar]

[25]Ghavami H, Ahmadi F, Entezami H, Meamarian R, The effect of continuous care model on diabetic patients’ blood pressure Iranian Journal of Medical Education 2006 6(1):87-95.  [Google Scholar]

[26]Valizadeh R, Moosazadeh M, Bahaadini K, Vali L, Lashkari T, Amiresmaili M, Determining the prevalence of retinopathy and its related factors among patients with type 2 diabetes in Kerman, Iran Osong Public Health and Research Perspectives 2016 7(5):296-300.10.1016/j.phrp.2016.08.00427812487  [Google Scholar]  [CrossRef]  [PubMed]

[27]Moayeri A, Mohamadpour M, Mousavi SF, Shirzadpour E, Mohamadpour S, Amraei M, Fracture risk in patients with type 2 diabetes mellitus and possible risk factors: a systematic review and meta-analysis Therapeutics and Clinical Risk Management 2017 14(1):455-68.10.2147/TCRM.S13194528442913  [Google Scholar]  [CrossRef]  [PubMed]

[28]Shahbodaghi Z, Borhani F, Rayani M, The effects of salf-care program on blood pressure of patients with diabetes Medical-Surgical Nursing Journal 2014 3(3):169  [Google Scholar]

[29]Abbasian M, Delvarianzadeh M, Evaluation of diabetes complications among the diabetic patients visiting the Shahroud diabetic’s clinic Knowledge and Health 2008 2(14):15-19.  [Google Scholar]

[30]Grobbee DE, How to ADVANCE prevention of cardiovascular complications in type 2 diabetes Metabolism-Clinical and Experimental 2003 52:24-28.10.1016/S0026-0495(03)00214-2  [Google Scholar]  [CrossRef]

[31]Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study Diabetes Research and Clinical Practice 1995 28(2):103-17.10.1016/0168-8227(95)01064-K  [Google Scholar]  [CrossRef]

[32]Raymond I, Nielsen TA, Lavigne G, Manzini C, Choinière M, Quality of sleep and its daily relationship to pain intensity in hospitalized adult burn patients PAIN® 2001 92(3):381-88.10.1016/S0304-3959(01)00282-2  [Google Scholar]  [CrossRef]

[33]Hashemi S, Tayebi A, Rahimi A, Einolahi B, Examining the effect of continuous care model on adherence to dietary regimen among patients receiving hemodialysis. J Crit Care Nurs 2015 7(4):215-20.  [Google Scholar]